この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2021/4/11 分で読めます
Revocation of Authorization of Emergency Use of a Medical Device During COVID-19; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorization (EUA) (the Authorization) issued to NovaSterilis, Inc. for the Nova2200 using the NovaClean decontamination process. FDA revoked the Authorization on February 12, 2021, under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocation, which includes an explanation of the reasons for the revocation, is reprinted in this document.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →